Deprescribing Medications that Increase the Risk of Falls in Older People: Exploring Doctors' Perspectives Using the Theoretical Domains Framework (TDF) DOI Open Access
R Kalim, Conal Cunningham, Sheila A. Ryder

et al.

Drugs & Aging, Journal Year: 2022, Volume and Issue: 39(12), P. 935 - 947

Published: Nov. 21, 2022

Language: Английский

Polypharmacy and Deprescribing in Older Adults DOI
Wade Thompson, Emily G. McDonald

Annual Review of Medicine, Journal Year: 2023, Volume and Issue: 75(1), P. 113 - 127

Published: Sept. 20, 2023

Older adults commonly end up on many medications. Deprescribing is an important part of individualizing care for older adults. It opportunity to discuss treatment options and revisit medications that may not have been reassessed in years. A large evidence base exists the field, suggesting deprescribing feasible safe, though questions remain about potential clinical benefits. research faces a myriad challenges, such as identifying employing optimal outcome measures. Further, there uncertainty which approaches are likely be most effective what contexts. Evidence barriers facilitators has underscored how routine practice can complex challenging. Thus, finding practical, sustainable ways implement priority future field.

Language: Английский

Citations

7

Deprescribing: A Prime Opportunity to Optimize Care of Cancer Patients DOI Creative Commons
Geneviève Chaput,

Hitesh Bhanabhai

Current Oncology, Journal Year: 2023, Volume and Issue: 30(11), P. 9701 - 9709

Published: Nov. 2, 2023

Patients with incurable cancers have an increasing number of comorbidities, which can lead to polypharmacy and its associated adverse events (drug-to-drug interaction, prescription a potentially inappropriate medication, drug event). Deprescribing is patient-centered process aimed at optimizing patient outcomes by discontinuing medication(s) deemed no longer necessary or inappropriate. Improved quality life, risk reduction side effects worse clinical outcomes, decrease in healthcare costs are well-documented benefits deprescribing. advance care planning both require consideration patients’ values, preferences, goals. Here, we provide overview comorbidities risks cancer patients, as well useful tools resources for deprescribing daily practice, shed light on how facilitate discussions patients who advanced limited life expectancy.

Language: Английский

Citations

7

Assessing community pharmacists’ attitudes towards identifying opportunities for deprescribing in clinical practice in Ireland DOI Open Access
Clara H. Heinrich, Maria D. Donovan

International Journal of Pharmacy Practice, Journal Year: 2021, Volume and Issue: 30(1), P. 28 - 35

Published: Nov. 30, 2021

The main objective of this study was to assess community pharmacists' thoughts regarding the role they can play in effectively integrating deprescribing into clinical practice Ireland. aim (1) knowledge deprescribing, (2) confidence (3) attitudes towards and (4) barriers facilitators a pharmacy setting.An online questionnaire disseminated pharmacists currently registered with Pharmaceutical Society Ireland, instruction only complete if working pharmacy. Statistical analysis conducted on quantitative data, whereas thematic carried out open-ended responses.Results indicate good scores positive surrounding demographic factors having no significant effect results. Although is high, willingness engage hindered by obstacles such as time. Remuneration identified an enabler for deprescribing. Interdisciplinary educational opportunities bidirectional communication channels prescribers are viewed major deprescribing.Community demonstrate that possess sufficient knowledge, greater facilitating To enable expansion, enablers education funding need be implemented, overcome insufficient Further studies required competence, their ability fulfil

Language: Английский

Citations

16

Attitudes Toward Deprescribing in Older Adults and Caregivers: A Survey in Quebec, Canada DOI Creative Commons
Bianca Rakheja, Caroline Sirois, Nicole Ouellet

et al.

Journal of Applied Gerontology, Journal Year: 2022, Volume and Issue: 41(5), P. 1376 - 1384

Published: March 4, 2022

This study aimed to describe attitudes toward deprescribing among older adults and caregivers. We recruited 110 65 years above using at least one prescribed medication for 3 months, 95 unrelated caregivers (18+) of with such characteristics, who answered the validated French version revised Patients' Attitudes Towards Deprescribing questionnaire. More (84.5%) than (70.5%) (p = .007) would be willing stop if doctor said it was possible. Conversely, 93.5% 78.9% were satisfied current medications taken .0024). The results did not vary according age, sex, number taken, education level, or residency. Thus, are disposed undertake deprescribing, regardless sociodemographic characteristics. However, relying solely on satisfaction may sufficient identify relevant opportunities.

Language: Английский

Citations

12

Deprescribing Medications that Increase the Risk of Falls in Older People: Exploring Doctors' Perspectives Using the Theoretical Domains Framework (TDF) DOI Open Access
R Kalim, Conal Cunningham, Sheila A. Ryder

et al.

Drugs & Aging, Journal Year: 2022, Volume and Issue: 39(12), P. 935 - 947

Published: Nov. 21, 2022

Language: Английский

Citations

12